1-3 of 3
Joan Admirand, MD
Close
Sort by
Journal Articles

ZAP70 Expression by Immunohistochemistry Correlates with IgVH Mutation Status in Chronic Lymphocytic Leukemia and Predicts Time to Progression, but Survival Is Decreased in p53-Positive CLL, Regardless of ZAP70 Expression.

Ellen J. Schlette, MD, Constantine Tam, MBBS, Joan Admirand, MD, William Wierda, MD, Susan O’Brien, MD, Susan Lerner, MS, Michael J. Keating, MBBS
Journal: Blood
Blood (2007) 110 (11): 3083.
https://doi.org/10.1182/blood.V110.11.3083.3083
Published: 2007
Journal Articles

ZAP-70 Status Does Not Predict Outcome after Nonmyeloablative Allogeneic Stem-Cell Transplantation (NST) in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) That Fails To Respond to Conventional Chemoimmunotherapy.

Issa F. Khouri, MD, Rima M. Saliba, PHD, Joan Admirand, MD, Susan O’Brien, MD, Ming-S. Lee, MD, Barry I. Samuels, MD, Sergio Giralt, MD, Marcos de Lima, MD, Michael J. Keating, MD, Richard E. Champlin, MD, Carlos Bueso-Ramos, MD
Journal: Blood
Blood (2006) 108 (11): 3028.
https://doi.org/10.1182/blood.V108.11.3028.3028
Published: 2006
Journal Articles

ZAP-70 Status May Not Predict Outcome after Non-Myeloablative Allogeneic Transplantation (NMT) in Patients with Chronic Lymphocytic Leukemia(CLL) Who Failed Conventional Chemotherapy.

Issa F. Khouri, MD, Rima M. Saliba, PhD, Michael J. Keating, MD, Joan Admirand, MD, Susan O’Brien, MD, Richard E. Champlin, MD, Carlos Buenos-Ramos, MD
Journal: Blood
Blood (2005) 106 (11): 2038.
https://doi.org/10.1182/blood.V106.11.2038.2038
Published: 2005